Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs.

Francica, Joseph R; Zak, Daniel E; Linde, Caitlyn; Siena, Emilio; Johnson, Carrie; Juraska, Michal; Yates, Nicole L; Gunn, Bronwyn; De Gregorio, Ennio; Flynn, Barbara J; Valiante, Nicholas M; Malyala, Padma; Barnett, Susan W; Sarkar, Pampi; Singh, Manmohan; Jain, Siddhartha; Ackerman, Margaret; Alam, Munir; Ferrari, Guido; Salazar, Andres; Tomaras, Georgia D; O'Hagan, Derek T; Aderem, Alan; Alter, Galit; Seder, Robert A

Francica, Joseph R; Zak, Daniel E; Linde, Caitlyn; Siena, Emilio; Johnson, Carrie; Juraska, Michal; Yates, Nicole L; Gunn, Bronwyn; De Gregorio, Ennio; Flynn, Barbara J; Valiante, Nicholas M; Malyala, Padma; Barnett, Susan W; Sarkar, Pampi; Singh, Manmohan; Jain, Siddhartha; Ackerman, Margaret; Alam, Munir; Ferrari, Guido; Salazar, Andres; Tomaras, Georgia D; O'Hagan, Derek T; Aderem, Alan; Alter, Galit; Seder, Robert A.

Afiliación

Francica JR; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
Zak DE; The Center for Infectious Disease Research, Seattle, WA.
Linde C; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, MA.
Siena E; Novartis Vaccines and Diagnostics, Cambridge, MA.
Johnson C; GlaxoSmithKline, Siena, Italy.
Juraska M; The Center for Infectious Disease Research, Seattle, WA.
Yates NL; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
Gunn B; Duke Human Vaccine Institute, Durham, NC.
De Gregorio E; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, MA.
Flynn BJ; Novartis Vaccines and Diagnostics, Cambridge, MA.
Valiante NM; GlaxoSmithKline, Siena, Italy.
Malyala P; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
Barnett SW; Novartis Vaccines and Diagnostics, Cambridge, MA.
Sarkar P; Moderna Therapeutics, Cambridge, MA.
Singh M; Novartis Vaccines and Diagnostics, Cambridge, MA.
Jain S; Novartis Vaccines and Diagnostics, Cambridge, MA.
Ackerman M; Bill & Melinda Gates Foundation, Washington, DC.
Alam M; Novartis Vaccines and Diagnostics, Cambridge, MA.
Ferrari G; Novartis Vaccines and Diagnostics, Cambridge, MA.
Salazar A; Takeda Pharmaceuticals, Cambridge, MA; and.
Tomaras GD; Novartis Vaccines and Diagnostics, Cambridge, MA.
O'Hagan DT; Thayer School of Engineering, Dartmouth College, Hanover, NH.
Aderem A; Duke Human Vaccine Institute, Durham, NC.
Alter G; Duke Human Vaccine Institute, Durham, NC.

Blood Adv ; 1(25): 2329-2342, 2017 11 28.

Article en En | MEDLINE | ID: mdl-29296883

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Qualitative_research Idioma: En Revista: Blood Adv Año: 2017 Tipo del documento: Article País de afiliación: Moldova

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google